Holtec Nuclear Corporation launched the roadshow for its Nasdaq IPO on September 8, 2026, offering 50 million Class A shares at $15 to $18 each to raise up to $900 million at a valuation of up to $10.2 billion, plus a 30-day option for 7.5 million more shares. The Camden, New Jersey company intends to list on Nasdaq and Nasdaq Texas under HNUC. J.P. Morgan, Guggenheim Securities, Goldman Sachs, Citigroup and BofA Securities are joint lead book-runners.
/ Sources
/ About this story
Compiled by Venture Atlas from the sources above, using automated AI-assisted research. This is a summary of reporting published elsewhere, not original reporting - follow the source links for the full account. See our editorial standards.
Something wrong here? Email apostructura@gmail.com and we will fix it.
/ Related
- NRC approves a one-time lift for a tilted Palisades assemblyMonday, October 19, 2026
- Holtec withdraws HNUC IPO registration with the SECSaturday, September 26, 2026
- Holtec pauses Palisades fuel loading after a tipped assemblyThursday, September 24, 2026
- Holtec postpones HNUC IPO, keeps SEC filingSaturday, September 19, 2026